Analysis of class II human leucocyte antigens in Italian and Spanish systemic sclerosis

Rheumatology

Volumn 51, Issue 1, 2012, Pages 52-59

  Beretta, Lorenzo ^a   Rueda, Blanca ^b   Marchini, Maurizio ^a   Santaniello, Alessandro ^a   Simeón, Carmen P ^c   Fonollosa, Vicente ^c   Caronni, Monica ^a   Rios fernandez, Raquel ^d   Carreira, Patricia ^e   Rodriguez rodriguez, Luis ^f   Moreno, Antonia ^g   López nevot, Miguel A ^g   Escalera, Ana ^h   González escribano, Maria F ^h   Martin, Javier ^b   Scorza, Raffaella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f Hospital Sant Pau   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Epidemiology; Genetics; HLA; Systemic sclerosis

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; OLIGONUCLEOTIDE;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROTEIN ANALYSIS; SPAIN; SYSTEMIC SCLEROSIS;

AUTOANTIBODIES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-D ANTIGENS; HLA-DQ ALPHA-CHAINS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; ITALY; SCLERODERMA, SYSTEMIC; SPAIN;

EID: 84855181107     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker335     Document Type: Article

References (32)

1. Silver RM. Clinical aspect of systemic sclerosis (scleroderma). Ann Rheum Dis 1991;50:854-61.
2. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117: 557-67.
3. Agarwal SK, Reveille JD. The genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol 2010;22:133-8.
4. Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 2008;34:17-40.
5. Arnett FC, Gourh P, Shete S et al. Major histocompatibility complex (MHC) class II alleles, haplotypes, and epitopes which confer susceptibility or protection in the fibrosing autoimmune disease systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010;69:822-7.
6. Briggs D, Welsh KI. Major histocompatibility complex class II genes and systemic sclerosis. Ann Rheum Dis 1991;50:862-5.
7. Simeó n CP, Fonollosa V, Tolosa C et al. Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol 2009;36:2733-6.
8. Frezza D, Giambra V, Tolusso B et al. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis 2007; 66:1210-5.
9. Favalli E, Ingegnoli F, Zeni S et al. [HLA typing in sistemi sclerosis]. Reumatismo 2001;53:210-4.
10. Vlachoyiannopoulos PG, Dafni UG, Pakas I et al. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele. Ann Rheum Dis 2000;59: 359-67.
11. Fanning GC, Welsh KI, Bunn C et al. HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol 1998;37: 201-7.
12. Hietarinta M, Ilonen J, Lassila O, Hietaharju A. Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma). Br J Rheumatol 1994;33:323-6.
13. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutics Criteria Committee. Arthritis Rheum 1980;23:581-90.
14. Hudson M, Taillefer S, Steele R et al. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007;25:754-7.
15. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 1988;15:202-5.
16. Le Roy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28: 1573-6.
17. Dalva K, Beksac M. Sequence-specific primed PCR (PCR-SSP) typing of HLA Class I and Class II alleles. Methods Mol Med 2007;134:51-60.
18. Good PI. Permutation tests. A practical guide to resampling methods for testing hypotheses. New York: Springer, 2000.
19. Cheverud JM. A simple correction for multiple comparisons in interval mapping genome scans. Heredity 2001;87: 52-8.
20. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
21. Bryc K, Velez C, Karafet T et al. Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci USA 2010;107:8954-61.
22. Bax L, Yu LM, Ikeda N et al. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006;6:50.
23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
24. Ong B, Willcox N, Wordsworth P et al. Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. Proc Natl Acad Sci USA 1991; 88:7343-7.
25. Busch R, Hill CM, Hayball JD et al. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. J Immunol 1991;147:1292-8.
26. Dick T, Mierau R, Bartz-Bazzanella P et al. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis 2002;1: 121-7.
27. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
28. Ferri C, Valentini G, Cozzi F et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine 2002;81:139-53.
29. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J Dermatol 2010;37:42-53.
30. Oshima M, Deitiker P, Atassi MZ. Targeting the antigen-binding site of HLA-restricting alleles in treatment of autoimmune disease. Crit Rev Immunol 2007;27: 271-88.
31. Ohyama H, Nishimura F, Meguro M et al. Counter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation. Cytokine 2002;17:175-81.
32. Scala E, Pallotta S, Frezzolini A et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004;138:540-6.